| # | Title | Journal | Year | Citations |
|---|
| 1 | Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS) | Pleura and Peritoneum | 2016 | 110 |
| 2 | Bidirectional chemotherapy in gastric cancer with peritoneal metastasis combining intravenous XELOX with intraperitoneal chemotherapy with low-dose cisplatin and Doxorubicin administered as a pressurized aerosol: an open-label, Phase-2 study (PIPAC-GA2) | Pleura and Peritoneum | 2019 | 57 |
| 3 | Pharmacological principles of intraperitoneal and bidirectional chemotherapy | Pleura and Peritoneum | 2017 | 53 |
| 4 | Photodynamic therapy and photothermal therapy for the treatment of peritoneal metastasis: a systematic review | Pleura and Peritoneum | 2018 | 51 |
| 5 | Functional vascular anatomy of the peritoneum in health and disease | Pleura and Peritoneum | 2019 | 48 |
| 6 | PIPAC EstoK 01: Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study | Pleura and Peritoneum | 2018 | 46 |
| 7 | Peritoneal innervation: embryology and functional anatomy | Pleura and Peritoneum | 2017 | 43 |
| 8 | Diverse properties of the mesothelial cells in health and disease | Pleura and Peritoneum | 2016 | 37 |
| 9 | Hypoxia, cytokines and stromal recruitment: parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis | Pleura and Peritoneum | 2018 | 36 |
| 10 | Electrostatic precipitation Pressurized IntraPeritoneal Aerosol Chemotherapy (ePIPAC): first in-human application | Pleura and Peritoneum | 2016 | 32 |
| 11 | Environmental safety during the administration of Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) | Pleura and Peritoneum | 2016 | 32 |
| 12 | Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design | Pleura and Peritoneum | 2018 | 31 |
| 13 | Experimental pharmacokinetics evaluation of chemotherapy delivery by PIPAC for colon cancer: first evidence for efficacy | Pleura and Peritoneum | 2017 | 30 |
| 14 | Pre-analytical issues in effusion cytology | Pleura and Peritoneum | 2016 | 29 |
| 15 | Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane™) for peritoneal carcinomatosis – a phase I first-in-human study | Pleura and Peritoneum | 2018 | 29 |
| 16 | PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer | Pleura and Peritoneum | 2018 | 27 |
| 17 | Resistance to anoikis in transcoelomic shedding: the role of glycolytic enzymes | Pleura and Peritoneum | 2019 | 27 |
| 18 | Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice | Pleura and Peritoneum | 2017 | 25 |
| 19 | Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy – PIPAC-OPC2 | Pleura and Peritoneum | 2018 | 25 |
| 20 | Multicystic peritoneal mesothelioma: a systematic review of the literature | Pleura and Peritoneum | 2019 | 25 |
| 21 | The role of Pressurized IntraPeritoneal Aerosol Chemotherapy in the management of gastric cancer: A systematic review | Pleura and Peritoneum | 2019 | 25 |
| 22 | Study protocol: phase 1 dose escalating study of Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) with oxaliplatin in peritoneal metastasis | Pleura and Peritoneum | 2018 | 24 |
| 23 | Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) as an outpatient procedure | Pleura and Peritoneum | 2018 | 23 |
| 24 | Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients | Pleura and Peritoneum | 2020 | 23 |
| 25 | Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) | Pleura and Peritoneum | 2017 | 22 |
| 26 | Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo naïve upper gi-adenocarcinomas with peritoneal seeding – a phase II/III trial of the AIO/CAOGI/ACO | Pleura and Peritoneum | 2018 | 21 |
| 27 | Morphology of the peritoneal cavity and pathophysiological consequences | Pleura and Peritoneum | 2016 | 20 |
| 28 | Cytoreductive Surgery (CRS) and Hyperthermic IntraPeritoneal Chemotherapy (HIPEC): don’t throw the baby out with the bathwater | Pleura and Peritoneum | 2018 | 20 |
| 29 | Therapeutic efficacy of systemic therapy for colorectal peritoneal carcinomatosis: surgeon’s perspective | Pleura and Peritoneum | 2018 | 20 |
| 30 | MESOTIP: Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy vs. systemic chemotherapy alone as 1st-line treatment of malignant peritoneal mesothelioma | Pleura and Peritoneum | 2019 | 20 |
| 31 | Early postoperative intraperitoneal chemotherapy for lower gastrointestinal neoplasms with peritoneal metastasis: a systematic review and critical analysis | Pleura and Peritoneum | 2019 | 20 |
| 32 | CRS and HIPEC in patients with peritoneal metastasis secondary to colorectal cancer: The small-bowel PCI score as a predictor of survival | Pleura and Peritoneum | 2019 | 20 |
| 33 | Modelling drug transport during intraperitoneal chemotherapy | Pleura and Peritoneum | 2017 | 18 |
| 34 | Animal models of colorectal peritoneal metastasis | Pleura and Peritoneum | 2016 | 17 |
| 35 | Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in resected high-risk colon cancer patients – study protocol for the PIPAC-OPC3 Trial. A prospective, controlled phase 2 Study | Pleura and Peritoneum | 2018 | 17 |
| 36 | Hyperthermic intraperitoneal chemotherapy with cisplatin and mitomycin C for colorectal cancer peritoneal metastases: A systematic review of the literature | Pleura and Peritoneum | 2019 | 17 |
| 37 | Practice patterns, attitudes, and knowledge among physicians regarding cytoreductive surgery and HIPEC for patients with peritoneal metastases | Pleura and Peritoneum | 2018 | 16 |
| 38 | Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC) | Pleura and Peritoneum | 2022 | 16 |
| 39 | A new ex vivo model for optimizing distribution of therapeutic aerosols: the (inverted) bovine urinary bladder | Pleura and Peritoneum | 2017 | 15 |
| 40 | Randomized controlled trials evaluating cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in prevention and therapy of peritoneal metastasis: a systematic review | Pleura and Peritoneum | 2016 | 14 |
| 41 | Randomized control trial comparing quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) and intravenous chemotherapy | Pleura and Peritoneum | 2018 | 14 |
| 42 | Survival outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from gastric cancer: a systematic review | Pleura and Peritoneum | 2016 | 13 |
| 43 | Pharmacokinetic problems in peritoneal drug administration: an update after 20 years | Pleura and Peritoneum | 2016 | 12 |
| 44 | Assessment of a novel mucolytic solution for dissolving mucus in pseudomyxoma peritonei: an ex vivo and in vitro study | Pleura and Peritoneum | 2017 | 12 |
| 45 | Comparison of GATA-3, mammaglobin, GCDFP-15 expression in breast carcinoma in serous effusions: A cell-block micro-array study | Pleura and Peritoneum | 2017 | 12 |
| 46 | Morbidity and mortality in women with advanced ovarian cancer who underwent primary cytoreductive surgery compared to cytoreductive surgery for recurrent disease: a meta-analysis | Pleura and Peritoneum | 2019 | 12 |
| 47 | Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial | Pleura and Peritoneum | 2020 | 12 |
| 48 | Cachexia-anorexia syndrome in patients with peritoneal metastasis: an observational study | Pleura and Peritoneum | 2016 | 11 |
| 49 | Preoperative intraperitoneal oxaliplatin for unresectable peritoneal carcinomatosis of colorectal origin: a pilot study | Pleura and Peritoneum | 2016 | 11 |
| 50 | Single-port access for Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC): technique, feasibility and safety | Pleura and Peritoneum | 2016 | 11 |
